Live Chat

AbbVie live chart

instrument_fundamentals

Weekly Search
Weekly
Daily
date إغلاق change معدل التغيير (%) instr__open مرتفع منخفض

Markets.com news

bitcoin dropping
Antonio Ferlito 2024 Aug 19, 16:05

Test News Article Arabic Only

CFD Trading BoE
French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

الأسبوع القادم: نتائج الانتخابات الفرنسية هامة بالنسبة للأسواق الأوروبية

الفوركس المؤشرات
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

الأسبوع القادم: هل تتسبب فرنسا في أزمة جديدة لليورو؟

CPI
RBA, SNB, Bank of England rate decisions due next week
markets.com Support Team 2024 Jun 13, 21:00

الأسبوع القادم: البنك الأسترالي، البنك البريطاني.. الثبات أم التغيير؟

الفوركس المؤشرات

معلومات

الفارق الهامشي

1.07

الهامش (%)

0.6252 %

الرافعة المالية

1:10

فائدة الشراء بين ليلة وضحاها

-0.0597 %

فائدة البيع بين ليلة وضحاها

-0.0292 %

عملة

USD

ساعات التداول

السوق مغلق

الثلاثاء

14:31 - 20:59

الاثنين

14:31-20:59

الأربعاء

14:31-20:59

الخميس

14:31-20:59

الجمعة

14:31-20:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

315240087552

instr__shares_outstand

1767139968

instr__earnings_date

0000-00-00

instr__dividend_date

2025-02-14

instr__ex_dividend_date

2025-01-15

instr__forward_annual_dividend_rate

6.56

instr__forward_annual_dividend_yield

0.0374

instr__eps

2.87

instrument_learn_more

AbbVie AbbVie Inc
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; Evolveimmune Therapeutics, Inc.; Genentech, Inc.; and Tentarix Biotherapeutics, LP. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

related_instruments

الأصل
البيع
شراء
معدل التغيير (%)
view_all_instruments
Trustpilot
Live Chat